Source abstract
Abstract
Despite significant therapeutic advances with chemotherapy and immunotherapy in some solid tumors, clinical outcomes for glioblastoma multiform (GBM) remain suboptimal. Owing to their high yield, easy accessibility and cost-effectiveness, plant-derived extracellular vehicles (EVs) have become attractive platforms for biomedical uses. Our study shows that fully natural ginger-derived exosomes (GEXO) effectively inhibited GBM progression through dual mechanisms: (a) direct activation of apoptotic pathways in GBM cells, and (b) induction of immunogenic cell death (ICD) that transforms dead tumor cells into endogenous vaccines. Mechanistically, GEXO demonstrated superior blood-brain barrier (BBB) penetration through clathrin-, caveolin- and macropinocytosis-mediated transcytosis, followed by tumor-specific accumulation via exocytosis. Transcriptomic analysis revealed that GEXO promoted an immunogenic shift in dying GBM cells, enhancing dendritic cell maturation and cytotoxic T-cell responses. In orthotopic GL261 and CT2A models, GEXO significantly prolonged survival without observable toxicity. The natural GEXO platform represents a promising, biosafe strategy with clinical potential for refractory GBM.
Source: openalex_inverted_index · Quality: baseline
Affiliations
Department of Critical Care Medicine and Department of Emergency Medicine
The First Affiliated Hospital of Zhengzhou University
International Joint Centre for Biomedical Innovation, Henan Key Laboratory of Brain Targeted Bio-nanomedicine, School of Life Sciences, Henan University, Jing Ming Avenue, Kaifeng, Henan 475004, P. R. China
School of Biomedical Engineering
University of Technology Sydney
Funding
Natural Science Foundation of Henan Province · China Postdoctoral Science Foundation · National Natural Science Foundation of China · Henan University